David C de Leeuw

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Chronic Kidney Disease

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A M Hofland, Mona M H E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J Scholten, Alexander N Snel, Costa Bachas, Jesse Marc Tettero, Dimitri A Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Arjan A van de Loosdrecht, Johan A Maertens, Markus Gabriel Manz, Thomas Pabst, Jakob R Passweg, Kimmo Porkka, Peter J M Valk, Patrycja L Gradowska, Bob Löwenberg, David C de Leeuw, Jeroen J W M Janssen, Gert J Ossenkoppele, Jacqueline Cloos
Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood (2023)
Daan W Huntjens, Jacob A Dijkstra, Lisanne N Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R A Welkers, Agnes I Veldkamp, Marianne A Kuijvenhoven, David C de Leeuw, Heshu Abdullah-Koolmees, Maria T Kuipers, Imke H Bartelink
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics 15 (1) (2023)
Daan W Huntjens, Jacob A Dijkstra, Lisanne N Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R A Welkers, Agnes I Veldkamp, Marianne A Kuijvenhoven, David C de Leeuw, Heshu Abdullah-Koolmees, Maria T Kuipers, Imke H Bartelink
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics 15 (1) (2023)
Daan W Huntjens, Jacob A Dijkstra, Lisanne N Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R A Welkers, Agnes I Veldkamp, Marianne A Kuijvenhoven, David C de Leeuw, Heshu Abdullah-Koolmees, Maria T Kuipers, Imke H Bartelink
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics 15 (1) (2023)
Jesse Marc Tettero, Yara Buisman, Lok Lam Ngai, Costa Bachas, Bjorn Tore Gjertsen, Angèle Kelder, Arjan A van de Loosdrecht, Markus Gabriel Manz, Thomas Pabst, Willemijn Scholten, Gert J Ossenkoppele, Jacqueline Cloos, David C de Leeuw
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere 7 (12) (2023)
Daan W Huntjens, Jacob A Dijkstra, Lisanne N Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R A Welkers, Agnes I Veldkamp, Marianne A Kuijvenhoven, David C de Leeuw, Heshu Abdullah-Koolmees, Maria T Kuipers, Imke H Bartelink
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics 15 (1) (2023)
David C de Leeuw, Gert J Ossenkoppele, Jeroen J W M Janssen
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment. Current oncology reports 24 (11) (2022)
Mila S Griffioen, David C de Leeuw, Jeroen J W M Janssen, Linda Smit
Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies. Cancers 14 (14) (2022)